Please login to the form below
Ebola
This page shows the latest Ebola news and features for those working in and with pharma, biotech and healthcare.
World Health Organization launches $2.54bn emergency health appeal
Thanks to the generous support of donors, we were able to respond to many health emergencies,” Ghebreyesus said, citing outbreaks of ebola in Uganda, cholera in 31 countries and m-pox
Latest news
-
WHO launches R&D efforts to identify pathogens that could cause future pandemics
The list, which is not exhaustive, currently includes COVID-19, Crimean-Cong haemorrhagic fever, Ebola virus disease and Marburg virus disease, Lassa fever, Middle East respiratory syndrome (MERS) and severe acute
-
EMA grants AZ’s Vaxzevria COVID-19 vaccine full marketing authorisation
The same technology has been used by scientists creating vaccines over the past 40 years in order to combat other infectious diseases, including flu, Zika, HIV and Ebola.
-
Merck to donate Sudan Ebola virus vaccine to International AIDS Vaccine Initiative
of its investigational Sudan Ebola virus vaccine candidate to the International AIDS Vaccine Initiative (IAVI), a global nonprofit scientific research organisation, for further clinical research use. ... IAVI looks forward to working with partners
-
AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
Vaxzevria is a ‘viral vector’ vaccine, a technology that is also used to create vaccines for other infectious diseases like flu, HIV and Ebola. ... This technology has been used by scientists for the past 40 years to fight other infectious diseases
-
Roche acquires test maker TIB Molbiol
virus H1N1 swine, Ebola virus, Zika virus and most recently, SARS-CoV-2 virus and its variants, said Roche.
More from news
Approximately 30 fully matching, plus 55 partially matching documents found.
Latest Intelligence
-
How will COVID-19 affect uptake of vaccinations against other diseases?
Robin Nandy, Principal Advisor &Chief of Immunizations at UNICEF, recently used the example of Ebola to caution against the dangers of secondary impacts on public health if planned vaccination delivery is ... neglected in the face of the current pandemic,
-
Has AI been the key to tackling the COVID-19 pandemic?
While the COVID-19 pandemic is reminiscent of public health emergencies like SARS and Ebola, the scale and reach of this pandemic brought us into completely new terrain – and with it,
-
COVID-19: the race to find a vaccine
Scientists have since industrialised the concept, leading to the development of antibodies against Ebola and respiratory syncytial virus. ... The same platform underpins CanSino’s Ebola vaccine that won approval in China in 2017.
-
Focusing on patient centricity to build trust in pharma
of Congo, officials enlisted faith-based networks to disseminate accurate health information to prevent the spread of Ebola.
-
As COVID-19 takes over the world, biopharma fights back
Prior to the coronavirus outbreak, Gilead had primarily been focused on testing remdesivir’s potential in Ebola virus disease, although the antiviral also demonstrated promise in other coronaviruses, including severe acute ... Although the drug was
More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.
Latest appointments
-
IFPMA elects Pfizer’s Ian Read as president
focus on the industry's efforts to develop treatments for the recent Ebola and Zika virus outbreaks.
-
Merck names head of strategic communications
Commenting on her appointment, Gerbeding said: “Whether containing the current Ebola outbreak, increasing vaccination rates or improving the overall health of people in communities, partnerships between public and private sector organisations
-
Sanofi names CSO Gary Nabel to Ebola role
Sanofi has appointed its chief scientific officer Gary Nabel as its Ebola response coordinator. ... an Ebola vaccine at NIH, Dr Nabel is uniquely qualified for this position.
-
Sanofi appoints NIH’s Gary Nabel as chief scientific officer
During this period, he provided overall direction of the VRC, including the development of notable vaccine strategies against HIV, ebola, bird flu and SARS.
More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Communicating the vaccine: how do we get the story right?
groups. There have been successful programmes to learn from, such as Ebola, which have shown the importance of respecting culture and diversity, and highlighted the need to localise messaging and content.
-
M3 (EU)
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an additional 1.8 million members via Networks in Health.
-
Australian Flu and the dilemma of naming diseases
such as Hendra, Lyme and Ebola.
-
Cool heads in a crisis?
First there was Ebola and now there is Zika; two official World Health Organization (WHO) Public Health Emergencies of International Concern (PHEIC) within as many years.
-
UK's department of Health deploys information campaign to ensure continued vigilance over Ebola
Five simple steps for GPs to follow if a patient presents with a suspected case of Ebola. • ... An updated info-graphic on the effect of the current outbreak of Ebola.
More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.
Subscribe to our email news alerts
- HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
No results were found
PMHub
An agency called Owen
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
